跳至主要内容
临床试验/NCT02934048
NCT02934048Unknown4 期

Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection

Shandong University0 个研究点目标入组 700 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
700
主要终点
The different rate of H. pylori eradication among 3 different course of treatments (7-day, 10-day and 14-day) guided by AST in per-protocol (PP) analysis.

研究概览

简要总结

Strongly evidence supports that H. pylori eradication is an effective approach to reduce the incidence of those pathologies. However, due to the increasing resistance rates to antibiotics, failures of H. pylori eradication get more and more common. Thus, rescue therapy for persistent H. pylori infection is becoming a grand challenge the investigators have to face.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients require upper endoscopy owing to persistent H. pylori infection despite one or more treatment attempts.

排除标准

  • Age younger than 18 years;
  • Patients with gastrectomy, acute GI bleeding and advanced gastric cancer;
  • Known or suspected allergy to study medications;
  • Inability to provide informed consent and other situations that could interfere with the examination or therapeutic protocol.

结局指标

主要结局

The different rate of H. pylori eradication among 3 different course of treatments (7-day, 10-day and 14-day) guided by AST in per-protocol (PP) analysis.

时间窗: 9 months

The different rate of H. pylori eradication among 3 different course of treatments (7-day, 10-day and 14-day) guided by AST in intention-to-treat (ITT) analysis.

时间窗: 9 months

次要结局

  • the rate of adverse events happening(9 months)
  • the rate of improving dyspepsia symptoms after H. pylori eradication(9 months)

研究者

发起方
Shandong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanqing Li

Vice president of Qilu Hospital

Shandong University

相似试验